More Evidence Of Anemia Drug Risk: FDA
Two new studies being examined by the U.S. Food and Drug Administration again indicate the risks of three anemia drugs, particularly when used by patients battling certain types of cancers with...To view the full article, register now.
Already a subscriber? Click here to view full article